Status:
UNKNOWN
Comparison Between Three Types of Stented Pericardial Aortic Valves
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
Edwards Lifesciences
Abbott Medical Devices
Conditions:
Aortic Valve Replacement
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This study suggests for the first time a comparison of the hemodynamic performance of the two most implanted aortic bioprosthesis in France with the new aortic bioprosthesis available since September ...
Detailed Description
According to the French database Society for Thoracic and Cardiovascular Surgery, 11,621 patients underwent aortic valve replacement in 2007. Over 77% of biologic prosthetic valves were used. Among th...
Eligibility Criteria
Inclusion
- Patients aged between 18 and 85 years who need aortic valve replacement (no endocarditis) With Bioprosthesis, with or without myocardial revascularization, with or without tricuspid valve repair surgery
Exclusion
- no endocarditis
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT01522352
Start Date
March 1 2012
End Date
December 1 2013
Last Update
September 4 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63003